PHI with Atrophoderma Pasini-Pierini
How does this condition affect your private health insurance?
Pasini-Krankheit, also known as Atrophoderma Pasini-Pierini (APP), is a rare, benign skin disorder characterized by progressively enlarging, sharply defined, depressed, hyperpigmented or bluish-brown patches. These asymptomatic lesions primarily affect the trunk and proximal extremities. It represents a form of localized dermal atrophy, with thinning of the dermis but without significant inflammation or systemic involvement. While its exact etiology is unknown, APP is often considered a variant of morphea (localized scleroderma) or a distinct entity. It typically emerges in adolescence or early adulthood, causing cosmetic concerns due to its persistent nature, though it is not life-threatening.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for lesions to become noticeable and progress.
Duration of Illness (Lifetime)
Chronic, typically lifelong with lesions persisting or slowly progressing.
Cost of Treatment (Initial)
Low to moderate, primarily for dermatological consultation and diagnostic biopsy (if needed).
Cost of Treatment (Lifetime)
Low, mainly for topical treatments (corticosteroids, vitamin D analogs) or occasional phototherapy; rarely systemic.
Mortality Rate
Negligible (nearly 0%) as it is a benign skin condition.
Risk of Secondary Damages
Low for physical damage (limited to cosmetic disfigurement); moderate for psychological impact (anxiety, self-consciousness).
Probability of Full Recovery
Low; lesions are typically persistent, though some stabilization or mild improvement may occur over time.
Underlying Disease Risk
Low to moderate, with the most common association being localized scleroderma (morphea); other autoimmune associations are rare and debated.